EP3852773A4 - Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof - Google Patents
Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof Download PDFInfo
- Publication number
- EP3852773A4 EP3852773A4 EP19861568.4A EP19861568A EP3852773A4 EP 3852773 A4 EP3852773 A4 EP 3852773A4 EP 19861568 A EP19861568 A EP 19861568A EP 3852773 A4 EP3852773 A4 EP 3852773A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- manufacture
- compositions derived
- cellular compositions
- graft tolerance
- deceased donors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001413 cellular effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862732827P | 2018-09-18 | 2018-09-18 | |
US201862732832P | 2018-09-18 | 2018-09-18 | |
US201862732823P | 2018-09-18 | 2018-09-18 | |
US201862732830P | 2018-09-18 | 2018-09-18 | |
PCT/US2019/051711 WO2020061180A1 (en) | 2018-09-18 | 2019-09-18 | Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3852773A1 EP3852773A1 (en) | 2021-07-28 |
EP3852773A4 true EP3852773A4 (en) | 2022-06-29 |
Family
ID=69887779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19861568.4A Pending EP3852773A4 (en) | 2018-09-18 | 2019-09-18 | Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3852773A4 (en) |
JP (1) | JP2022502483A (en) |
CN (1) | CN113164517A (en) |
AU (1) | AU2019344937A1 (en) |
CA (1) | CA3112320A1 (en) |
WO (1) | WO2020061180A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11697799B2 (en) | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
EP3980036A4 (en) * | 2019-06-06 | 2023-01-25 | Medeor Therapeutics, Inc. | Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells |
WO2022020210A1 (en) | 2020-07-18 | 2022-01-27 | Ossium Health, Inc. | Permeation of whole vertebral bodies with a cryoprotectant using vacuum assisted diffusion |
CA3195653A1 (en) | 2020-10-14 | 2022-04-21 | Ossium Health, Inc. | Systems and methods for extraction and cryopreservation of bone marrow |
CN117279650A (en) | 2020-12-18 | 2023-12-22 | 奥瑟姆健康公司 | Cell therapy method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2648354C2 (en) * | 2011-12-22 | 2018-03-23 | Иеда Рисеч Энд Девелопмент Ко. Лтд. | Combination therapy for stable and long term engraftment using specific protocols for t/b-cell depletion |
EP3804735A1 (en) * | 2013-02-26 | 2021-04-14 | The Board of Trustees of the Leland Stanford Junior University | Combined organ and hematopoietic cells for transplantation tolerance of grafts |
US10881692B2 (en) * | 2018-04-05 | 2021-01-05 | Medeor Therapeutics, Inc. | Compositions for establishing mixed chimerism and methods of manufacture thereof |
-
2019
- 2019-09-18 CA CA3112320A patent/CA3112320A1/en active Pending
- 2019-09-18 JP JP2021539495A patent/JP2022502483A/en active Pending
- 2019-09-18 CN CN201980075888.6A patent/CN113164517A/en active Pending
- 2019-09-18 WO PCT/US2019/051711 patent/WO2020061180A1/en unknown
- 2019-09-18 EP EP19861568.4A patent/EP3852773A4/en active Pending
- 2019-09-18 AU AU2019344937A patent/AU2019344937A1/en active Pending
Non-Patent Citations (3)
Title |
---|
LINK H ET AL: "Combined transplantation of allogeneic bone marrow and CD34+ blood cells", BLOOD, 1 October 1995 (1995-10-01), pages 2500 - 2508, XP055889577, Retrieved from the Internet <URL:https://ashpublications.org/blood/article-pdf/86/7/2500/622137/2500.pdf> [retrieved on 20220209], DOI: 10.1182/blood.V86.7.2500.bloodjournal8672500 * |
See also references of WO2020061180A1 * |
ZUBER JULIEN ET AL: "Mechanisms of Mixed Chimerism-Based Transplant Tolerance", TRENDS IN IMMUNOLOGY, vol. 38, no. 11, 1 November 2017 (2017-11-01), pages 829 - 843, XP085273403, ISSN: 1471-4906, DOI: 10.1016/J.IT.2017.07.008 * |
Also Published As
Publication number | Publication date |
---|---|
JP2022502483A (en) | 2022-01-11 |
AU2019344937A1 (en) | 2021-04-08 |
CA3112320A1 (en) | 2020-03-26 |
CN113164517A (en) | 2021-07-23 |
WO2020061180A1 (en) | 2020-03-26 |
EP3852773A1 (en) | 2021-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3852773A4 (en) | Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof | |
EP3589291A4 (en) | Compositions and methods for inhibition of lineage specific proteins | |
EP3697820A4 (en) | Methods and compositions relating to engineered regulatory t cells | |
EP3635095A4 (en) | Liver organoid compositions and methods of making and using same | |
EP3328455A4 (en) | Preparation of acellular cartilage graft and uses thereof | |
EP3790861A4 (en) | Senolytic compositions and uses thereof | |
EP3813856A4 (en) | Cell compositions and uses thereof | |
EP3808357A4 (en) | Composition and uses thereof | |
EP3474665A4 (en) | Viable lyophilized compositions derived from human tissues and methods of making the same | |
EP3589716A4 (en) | Adhesion enhancement compositions | |
EP3630846A4 (en) | Compositions and methods of cellular immunotherapy | |
EP3615490A4 (en) | Compositions and methods of biologically cemented structures for marine applications | |
EP3843729A4 (en) | Novel compositions and methods | |
EP3899538A4 (en) | Compositions of streptavidin-oligo conjugates of pmhc occupancy | |
PH12017502277A1 (en) | Multi-specific binding proteins | |
MX2019005933A (en) | Bispecific polypeptides to gitr and ctla-4. | |
EP3836938A4 (en) | Solid forms of substituted benzoxaborole and compositions thereof | |
EP3491329A4 (en) | Propellant and self-protection compositions | |
EP3448947A4 (en) | Lignin-containing sealant and/or coating compositions from renewable sources | |
EP3307336A4 (en) | Biomaterial compositions, implants, and methods of making the same | |
EP3773634A4 (en) | Cellular compositions derived from prior organ donors and methods of manufacture and use thereof | |
EP3890769A4 (en) | Engineered flagellin-derived compositions and uses | |
EP3635059A4 (en) | Construction materials, compositions and methods of making same | |
EP3478325A4 (en) | Elimination of proliferating cells from stem cell-derived grafts | |
EP3820996A4 (en) | Haloperoxidase compositions and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210407 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220601 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 5/0789 20100101ALI20220525BHEP Ipc: C12N 5/071 20100101ALI20220525BHEP Ipc: A61P 37/06 20060101ALI20220525BHEP Ipc: A61K 41/00 20200101ALI20220525BHEP Ipc: A61K 35/28 20150101AFI20220525BHEP |